1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Stem Cell Revenue
1.4 Market by Type
1.4.1 Global Cancer Stem Cell Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cell Culturing
1.4.3 Cell Separation
1.4.4 Cell Analysis
1.4.5 Molecular Analysis
1.4.6 Others
1.5 Market by Application
1.5.1 Global Cancer Stem Cell Market Share by Application: 2020 VS 2026
1.5.2 Stem Cell Based Cancer Therapy
1.5.3 Targeted CSCs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cancer Stem Cell Market Perspective (2015-2026)
2.2 Global Cancer Stem Cell Growth Trends by Regions
2.2.1 Cancer Stem Cell Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Stem Cell Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Stem Cell Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Stem Cell Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Stem Cell Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cancer Stem Cell Players by Market Size
3.1.1 Global Top Cancer Stem Cell Players by Revenue (2015-2020)
3.1.2 Global Cancer Stem Cell Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Stem Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Stem Cell Market Concentration Ratio
3.2.1 Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Stem Cell Revenue in 2019
3.3 Cancer Stem Cell Key Players Head office and Area Served
3.4 Key Players Cancer Stem Cell Product Solution and Service
3.5 Date of Enter into Cancer Stem Cell Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Stem Cell Historic Market Size by Type (2015-2020)
4.2 Global Cancer Stem Cell Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cancer Stem Cell Market Size by Application (2015-2020)
5.2 Global Cancer Stem Cell Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Stem Cell Market Size (2015-2020)
6.2 Cancer Stem Cell Key Players in North America (2019-2020)
6.3 North America Cancer Stem Cell Market Size by Type (2015-2020)
6.4 North America Cancer Stem Cell Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cancer Stem Cell Market Size (2015-2020)
7.2 Cancer Stem Cell Key Players in Europe (2019-2020)
7.3 Europe Cancer Stem Cell Market Size by Type (2015-2020)
7.4 Europe Cancer Stem Cell Market Size by Application (2015-2020)
8 China
8.1 China Cancer Stem Cell Market Size (2015-2020)
8.2 Cancer Stem Cell Key Players in China (2019-2020)
8.3 China Cancer Stem Cell Market Size by Type (2015-2020)
8.4 China Cancer Stem Cell Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cancer Stem Cell Market Size (2015-2020)
9.2 Cancer Stem Cell Key Players in Japan (2019-2020)
9.3 Japan Cancer Stem Cell Market Size by Type (2015-2020)
9.4 Japan Cancer Stem Cell Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cancer Stem Cell Market Size (2015-2020)
10.2 Cancer Stem Cell Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Stem Cell Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Stem Cell Market Size by Application (2015-2020)
11 India
11.1 India Cancer Stem Cell Market Size (2015-2020)
11.2 Cancer Stem Cell Key Players in India (2019-2020)
11.3 India Cancer Stem Cell Market Size by Type (2015-2020)
11.4 India Cancer Stem Cell Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cancer Stem Cell Market Size (2015-2020)
12.2 Cancer Stem Cell Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Stem Cell Market Size by Type (2015-2020)
12.4 Central & South America Cancer Stem Cell Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Thermo Fisher Scientific, Inc.
13.1.1 Thermo Fisher Scientific, Inc. Company Details
13.1.2 Thermo Fisher Scientific, Inc. Business Overview
13.1.3 Thermo Fisher Scientific, Inc. Cancer Stem Cell Introduction
13.1.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2015-2020))
13.1.5 Thermo Fisher Scientific, Inc. Recent Development
13.2 AbbVie, Inc.
13.2.1 AbbVie, Inc. Company Details
13.2.2 AbbVie, Inc. Business Overview
13.2.3 AbbVie, Inc. Cancer Stem Cell Introduction
13.2.4 AbbVie, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
13.2.5 AbbVie, Inc. Recent Development
13.3 Merck KGaA
13.3.1 Merck KGaA Company Details
13.3.2 Merck KGaA Business Overview
13.3.3 Merck KGaA Cancer Stem Cell Introduction
13.3.4 Merck KGaA Revenue in Cancer Stem Cell Business (2015-2020)
13.3.5 Merck KGaA Recent Development
13.4 Bionomics
13.4.1 Bionomics Company Details
13.4.2 Bionomics Business Overview
13.4.3 Bionomics Cancer Stem Cell Introduction
13.4.4 Bionomics Revenue in Cancer Stem Cell Business (2015-2020)
13.4.5 Bionomics Recent Development
13.5 Lonza
13.5.1 Lonza Company Details
13.5.2 Lonza Business Overview
13.5.3 Lonza Cancer Stem Cell Introduction
13.5.4 Lonza Revenue in Cancer Stem Cell Business (2015-2020)
13.5.5 Lonza Recent Development
13.6 Stemline Therapeutics, Inc.
13.6.1 Stemline Therapeutics, Inc. Company Details
13.6.2 Stemline Therapeutics, Inc. Business Overview
13.6.3 Stemline Therapeutics, Inc. Cancer Stem Cell Introduction
13.6.4 Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
13.6.5 Stemline Therapeutics, Inc. Recent Development
13.7 Miltenyi Biotec
13.7.1 Miltenyi Biotec Company Details
13.7.2 Miltenyi Biotec Business Overview
13.7.3 Miltenyi Biotec Cancer Stem Cell Introduction
13.7.4 Miltenyi Biotec Revenue in Cancer Stem Cell Business (2015-2020)
13.7.5 Miltenyi Biotec Recent Development
13.8 PromoCell GmbH
13.8.1 PromoCell GmbH Company Details
13.8.2 PromoCell GmbH Business Overview
13.8.3 PromoCell GmbH Cancer Stem Cell Introduction
13.8.4 PromoCell GmbH Revenue in Cancer Stem Cell Business (2015-2020)
13.8.5 PromoCell GmbH Recent Development
13.9 MacroGenics, Inc.
13.9.1 MacroGenics, Inc. Company Details
13.9.2 MacroGenics, Inc. Business Overview
13.9.3 MacroGenics, Inc. Cancer Stem Cell Introduction
13.9.4 MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
13.9.5 MacroGenics, Inc. Recent Development
13.10 OncoMed Pharmaceuticals, Inc.
13.10.1 OncoMed Pharmaceuticals, Inc. Company Details
13.10.2 OncoMed Pharmaceuticals, Inc. Business Overview
13.10.3 OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Introduction
13.10.4 OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
13.10.5 OncoMed Pharmaceuticals, Inc. Recent Development
13.11 Irvine Scientific
10.11.1 Irvine Scientific Company Details
10.11.2 Irvine Scientific Business Overview
10.11.3 Irvine Scientific Cancer Stem Cell Introduction
10.11.4 Irvine Scientific Revenue in Cancer Stem Cell Business (2015-2020)
10.11.5 Irvine Scientific Recent Development
13.12 STEMCELL Technologies Inc.
10.12.1 STEMCELL Technologies Inc. Company Details
10.12.2 STEMCELL Technologies Inc. Business Overview
10.12.3 STEMCELL Technologies Inc. Cancer Stem Cell Introduction
10.12.4 STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2015-2020)
10.12.5 STEMCELL Technologies Inc. Recent Development
13.13 Sino Biological Inc.
10.13.1 Sino Biological Inc. Company Details
10.13.2 Sino Biological Inc. Business Overview
10.13.3 Sino Biological Inc. Cancer Stem Cell Introduction
10.13.4 Sino Biological Inc. Revenue in Cancer Stem Cell Business (2015-2020)
10.13.5 Sino Biological Inc. Recent Development
13.14 BIOTIME, Inc.
10.14.1 BIOTIME, Inc. Company Details
10.14.2 BIOTIME, Inc. Business Overview
10.14.3 BIOTIME, Inc. Cancer Stem Cell Introduction
10.14.4 BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
10.14.5 BIOTIME, Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Thermo Fisher Scientific, Inc.、AbbVie, Inc.、Merck KGaA、Bionomics、Lonza、Stemline Therapeutics, Inc.、Miltenyi Biotec、PromoCell GmbH、MacroGenics, Inc.、OncoMed Pharmaceuticals, Inc.、Irvine Scientific、STEMCELL Technologies Inc.、Sino Biological Inc.、BIOTIME, Inc.
【免責事項】
https://www.globalresearch.jp/disclaimer